Accuris PR1001-HF-200 - High Fidelity Master Mix

Name: Accuris PR1001-HF-200 - High Fidelity Master Mix
Brand: Accuris
SKU: AccurisPR1001-HF-200
Price: 149.09 USD
Availability: InStock

0 reviews | Catalog: PR1001-HF-200 | Model: Accuris PR1001-HF-200

Compare

High Fidelity Master Mix, 200 rxns

High Fidelity Master Mix, 200 x 25 µL
Low Error Rates for Cloning, Sequencing & Mutagenesis
Two High Fidelity mixes available for a range of applications
Highly tolerant of PCR inhibitors
Exceptionally sensitive for low copy number templates
Options for TA or blunt-end cloning

View Product Details

List Price: $175.40

Your Price: $149.09

Sign-in for EDU Pricing!

In Stock:

View Payment Options

Request Quote

Items in This Series



Product	Accuris PR1001-HF-200 High Fidelity Master Mix, 200 rxns	Accuris PR1001-HFHS-500 High Fidelity Hot Start Master Mix, 500 rxns	Accuris PR1001-HFHS-200 High Fidelity Hot Start Master Mix, 200 rxns	Accuris PR1001-HF-500 High Fidelity Master Mix, 500 rxns	Accuris PR1001-HFHS-S High Fidelity Hot Start Master Mix, sample, 5 rxns	Accuris PR1001-HF-S High Fidelity PCR Master Mix, sample, 5 rxns
Price
In Stock
Compare	Add to compare	Add to compare	Add to compare	Add to compare	Add to compare	Add to compare

Recommended for you

Accuris PR1001-HF-200

Generates blunt ends
Rapid extension: up to 1 kb per 15 seconds
100X greater fidelity than native Taq
Ideal for shorter, less complex targets

High Fidelity Master Mix

Accuris High Fidelity Master Mix is perfect for shorter, less complex targets. Our 2X formulation provides extreme sensitivity in low copy number assays with 100X the fidelity of native Taq. The 2X master mix contains proprietary enhancers and a proof-reading component for troublefree PCR reaction assembly and performance. The preoptimized mix is supplied in a single tube, reducing the number of pipetting steps while improving throughput and reproducibility. Accuris High Fidelity Master Mix delivers a unique balance of PCR sensitivity, high fidelity, versatility, and tolerance to inhibitors.